Use of platelet-rich plasma in regenerative medicine: technical tools for correct quality control
Hajer Graiet(Inserm), Jérémy Magalon(Inserm), Françoise Dignat‐George(Inserm), Yaël Berda‐Haddad(Assistance Publique Hôpitaux de Marseille), Julie Véran(Inserm), Maxime Loyens(Hôpital de la Conception), Fanny Grimaud(Inserm), Pauline François(Inserm), Anna Lokchine(Inserm), Florence Sabatier(Aix-Marseille Université), Mélanie Velier(Inserm)
Cited by 20
Related Papers
MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments
|Journal of Extracellular Vesicles|2020|514
A compendium of single extracellular vesicle flow cytometry
|Journal of Extracellular Vesicles|2023|248
Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence
|Journal of Cellular and Molecular Medicine|2008|226
Transplanted Late Outgrowth Endothelial Progenitor Cells as Cell Therapy Product for Stroke
|Stem Cell Reviews and Reports|2010|153
Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential
|Journal of Thrombosis and Haemostasis|2012|75